Your browser doesn't support javascript.
loading
Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study.
Ivy, Dunbar; Bonnet, Damien; Berger, Rolf M F; Meyer, Gisela M B; Baygani, Simin; Li, Baohui.
Affiliation
  • Ivy D; University of Colorado Denver School of Medicine, Aurora, CO, USA.
  • Bonnet D; Centre de Référence Malformations Cardiaques Congénitales Complexes, M3C-Necker, Hôpital Necker-Enfants Malades, Université de Paris, Paris, France.
  • Berger RMF; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Meyer GMB; Pulmonary Hypertension Group, Santa Casa de Porto Alegre, Rio Grande Do Sul, Brazil.
  • Baygani S; Eli Lilly and Company, Indianapolis, IN, USA.
  • Li B; Eli Lilly and Company, Indianapolis, IN, USA.
Pulm Circ ; 11(3): 20458940211024955, 2021.
Article in En | MEDLINE | ID: mdl-34234945
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Pulm Circ Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Pulm Circ Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States